Chengdu Easton (China) Performance
| 688513 Stock | 36.20 1.17 3.13% |
On a scale of 0 to 100, Chengdu Easton holds a performance score of 10. The firm shows a Beta (market volatility) of -0.23, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Chengdu Easton are expected to decrease at a much lower rate. During the bear market, Chengdu Easton is likely to outperform the market. Please check Chengdu Easton's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Chengdu Easton's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Chengdu Easton Biopharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Chengdu Easton sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 821.9 M |
Chengdu |
Chengdu Easton Relative Risk vs. Return Landscape
If you would invest 3,060 in Chengdu Easton Biopharmaceuticals on January 17, 2025 and sell it today you would earn a total of 560.00 from holding Chengdu Easton Biopharmaceuticals or generate 18.3% return on investment over 90 days. Chengdu Easton Biopharmaceuticals is generating 0.3235% of daily returns and assumes 2.4001% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than Chengdu, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Chengdu Easton Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chengdu Easton's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chengdu Easton Biopharmaceuticals, and traders can use it to determine the average amount a Chengdu Easton's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1348
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688513 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.4 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Chengdu Easton is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chengdu Easton by adding it to a well-diversified portfolio.
Chengdu Easton Fundamentals Growth
Chengdu Stock prices reflect investors' perceptions of the future prospects and financial health of Chengdu Easton, and Chengdu Easton fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chengdu Stock performance.
| Return On Equity | 0.0896 | ||||
| Return On Asset | 0.034 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 5.15 B | ||||
| Shares Outstanding | 176.53 M | ||||
| Price To Book | 2.39 X | ||||
| Price To Sales | 4.80 X | ||||
| Revenue | 1.12 B | ||||
| EBITDA | 322.59 M | ||||
| Total Debt | 180.95 M | ||||
| Book Value Per Share | 15.36 X | ||||
| Cash Flow From Operations | 275.25 M | ||||
| Earnings Per Share | 1.43 X | ||||
| Total Asset | 3.35 B | ||||
| Retained Earnings | 979.58 M | ||||
About Chengdu Easton Performance
By analyzing Chengdu Easton's fundamental ratios, stakeholders can gain valuable insights into Chengdu Easton's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chengdu Easton has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chengdu Easton has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Chengdu Easton Bioph performance evaluation
Checking the ongoing alerts about Chengdu Easton for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chengdu Easton Bioph help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 55.0% of the company shares are owned by insiders or employees |
- Analyzing Chengdu Easton's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chengdu Easton's stock is overvalued or undervalued compared to its peers.
- Examining Chengdu Easton's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chengdu Easton's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chengdu Easton's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chengdu Easton's stock. These opinions can provide insight into Chengdu Easton's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chengdu Stock analysis
When running Chengdu Easton's price analysis, check to measure Chengdu Easton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chengdu Easton is operating at the current time. Most of Chengdu Easton's value examination focuses on studying past and present price action to predict the probability of Chengdu Easton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chengdu Easton's price. Additionally, you may evaluate how the addition of Chengdu Easton to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |